A systematic review of validated methods for identifying lymphoma using administrative data

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue SUPPL. 1, 2012, Pages 203-212

  Herman, Ronald A ^a   Gilchrist, Bradley ^a   Link, Brian K ^b   Carnahan, Ryan ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Administrative data; International Classification of Diseases; Lymphoma; Positive predictive value; Sensitivity; Specificity; Validity

Indexed keywords

ALGORITHM; ARTICLE; CANADA; CANCER THERAPY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LYMPHOMA; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; UNITED STATES; VALIDATION STUDY; VALIDITY;

ALGORITHMS; CANADA; DATABASES, FACTUAL; HUMANS; LYMPHOMA; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; REGISTRIES; SENSITIVITY AND SPECIFICITY; UNITED STATES; VALIDATION STUDIES AS TOPIC;

EID: 84856039639     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2315     Document Type: Article

References (24)

1. Roman E, Smith AG. Epidemiology of lymphomas. Histopathology 2011; 58(1): 4-14. DOI: 10.1111/j.1365-2559.2010.03696.x
2. Weisenburger DD. Pathological classification of non-Hodgkin's lymphoma for epidemiological studies. Cancer Res 1992; 52(19 Suppl): 5456s-5462s.
3. Herrinton LJ. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev 1998; 20(2): 187-203.
4. Aisenberg AC. Historical review of lymphomas. Br J Haematol 2000; 109(3): 466-476. DOI: 10.1046/j.1365-2141.2000.01988.x
5. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol 2000; 11(Suppl 1): 3-10.
6. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 110(2): 695-708. DOI: 10.1182/blood-2006-11-051672
7. Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008; 112(12): 4384-4399. DOI: 10.1182/blood-2008-07-077982
8. Carnahan RM, Moores KG. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012; 21(S1): 82-89.
9. Setoguchi S, Solomon DH, Glynn RJ, Cook EF, Levin R, Schneeweiss S. Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data. Cancer Causes Control 2007; 18(5): 561-569. DOI: 10.1007/s10552-007-0131-1
10. Bernstein CN, Nabalamba A. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol 2007; 21(8): 507-511.
11. Caillard S, Agodoa LY, Bohen EM, Abbott KC. Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis. Transplantation 2006; 81(6): 888-895. DOI: 10.1097/01.tp.0000203554.54242.56
12. Dalager NA, Kang HK, Burt VL, Weatherbee L. Hodgkin's disease and Vietnam service. Ann Epidemiol 1995; 5(5): 400-406. DOI: 10.1016/1047-2797(95)00038-9
13. Dalager NA, Kang HK, Burt VL, Weatherbee L. Non-Hodgkin's lymphoma among Vietnam veterans. J Occup Med 1991; 33(7): 774-779.
14. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4(6): 905-913. DOI: 10.1111/j.1600-6143.2004.00450.x
15. McGinnis KA, Fultz SL, Skanderson M, Conigliaro J, Bryant K, Justice AC. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse. J Clin Oncol 2006; 24(31): 5005-5009. DOI: 10.1200/JCO.2006.05.7984
16. Namboodiri KK, Harris RE. Hematopoietic and lymphoproliferative cancer among male veterans using the Veterans Administration Medical System. Cancer 1991; 68(5): 1123-1130. DOI: 10.1002/1097-0142(19910901)
17. Shea AM, Curtis LH, Hammill BG, DiMartino LD, Abernethy AP, Schulman KA. Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. JAMA 2008; 300(2): 189-196. DOI: 10.1001/jama.300.2.189
18. Smith JM, Rudser K, Gillen D, et al. Risk of lymphoma after renal transplantation varies with time: an analysis of the United States Renal Data System. Transplantation 2006; 81(2): 175-180. DOI: 10.1097/01.tp.0000188687.18972.a8
19. Watanabe KK, Kang HK, Thomas TL. Mortality among Vietnam veterans: with methodological considerations. J Occup Med 1991; 33(7): 780-785.
20. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10(12): 1419-1432.
21. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107(0031): 265-276. DOI: 10.1182/blood-2005-06-2508
22. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999; 8(12): 1117-1121.
23. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114(5): 937-951. DOI: 10.1182/blood-2009-03-209262
24. Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 2006; 15(4): 630-638. DOI: 10.1158/1055-9965.EPI-05-0549